BICARA THERAPEUTICS INC
BCAX·055477103·US·Common Stock·Healthcare - Biotechnology-Activist
BCAX (BICARA THERAPEUTICS INC) is held by 88 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($144.3M), Janus Henderson Group Ltd. ($66.4M), BlackRock, Inc. ($56.6M). Net institutional sentiment: Mixed.
88
Holders
Avg rating(19 Elite)
$621.8M
Total Value
55% (96)
Fund Consensus
49 buying - 40 selling
Who's Trading
InsiderMCMazumdar ClaireSell $283KJul 10, 2026
InsiderMCMazumdar ClaireSell $831.04Jul 10, 2026
InsiderCRCohlhepp RyanSell $16KJul 9, 2026
InsiderCRCohlhepp RyanSell $657KJul 8, 2026
InsiderCRCohlhepp RyanSell $128KJul 8, 2026
InsiderCRCohlhepp RyanSell $33KJul 8, 2026
InsiderHIHyep IvanSell $651KJul 8, 2026
InsiderHIHyep IvanSell $132KJul 8, 2026
ActivistDTDeep Track Capital, LP6.2%May 15, 2026
ActivistVPVestal Point Capital, LP8.3%May 15, 2026
13F: Insider & Congress:
Showing 1-20 of 96
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer